Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutical Companies enters into an agreement with the U.S. government for the delivery of 100M doses of COVID-19 vaccine Ad26.COV2.S.
BARDA, collaborating with the Department of Defense, is committing over $1B to the deal.
The feds may buy an additional 200M doses under a subsequent contract.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.